2024 - Pandemic Preparedness: Agility in Vaccine, Diagnostics and Therapeutics Development
Date2024-11-01
Deadline2024-11-01
VenueONLINE-VIRTUAL, USA - United States
KeywordsLife Sciences; Pharmaceutical; Pharma Manufacturing & Supply Chain
Topics/Call fo Papers
Pandemic preparedness is a continual process to ensure that when the need arises, drug developers, industry partners and government agencies can come together to proactively address emerging public health threats.
Close and careful coordination across stakeholders is vital to successfully addressing emergent and present threats to public health, especially when response is needed on a global scale. Key to preparation is the advanced identification of resource gaps and strategic response blind spots. This introspective analysis is critical to creating a strong foundation for robust pandemic response strategy by enabling the early identification of partners who can effectively support response efforts.
Coordinating with multiple partners, especially in times of crisis and uncertainty, is not without its challenges. This webinar will explore how a full-service clinical research organization (CRO) having contract development and manufacturing organization (CDMO) capabilities approaches pandemic preparedness to ensure a comprehensive and coordinated response with the necessary agility and speed to address public health emergencies.
The expert speakers will discuss how they can collaborate to expedite therapeutic and vaccine development when time is of the absolute essence and share real-world examples and lessons learned.
Register for this webinar today to learn how to enhance pandemic preparedness by establishing relevant partnerships that can help expedite therapeutic and vaccine development.
Keywords: Drug Development, Pandemic, Clinical Research, CRO, Patient Recruitment, Clinical Operations, Diagnostics, Laboratory Technology, Pandemic Preparedness, Sites, CDMO/CMO
Close and careful coordination across stakeholders is vital to successfully addressing emergent and present threats to public health, especially when response is needed on a global scale. Key to preparation is the advanced identification of resource gaps and strategic response blind spots. This introspective analysis is critical to creating a strong foundation for robust pandemic response strategy by enabling the early identification of partners who can effectively support response efforts.
Coordinating with multiple partners, especially in times of crisis and uncertainty, is not without its challenges. This webinar will explore how a full-service clinical research organization (CRO) having contract development and manufacturing organization (CDMO) capabilities approaches pandemic preparedness to ensure a comprehensive and coordinated response with the necessary agility and speed to address public health emergencies.
The expert speakers will discuss how they can collaborate to expedite therapeutic and vaccine development when time is of the absolute essence and share real-world examples and lessons learned.
Register for this webinar today to learn how to enhance pandemic preparedness by establishing relevant partnerships that can help expedite therapeutic and vaccine development.
Keywords: Drug Development, Pandemic, Clinical Research, CRO, Patient Recruitment, Clinical Operations, Diagnostics, Laboratory Technology, Pandemic Preparedness, Sites, CDMO/CMO
Other CFPs
- Antibody-Drug Conjugates: Bridging Precision and Potency in Oncology
- Achieving Realistic Patient Enrollment Goals: A Fireside Chat on Collaborative Success
- Harnessing Biomarker Discovery and Implementation in Clinical Trials with Novel Liquid Biopsy mRNA Gene Signatures
- Plant-based Proteins: Challenges and New Solutions
- Transforming Clinical Data Management with Clinical Data and Analytics Platforms
Last modified: 2024-10-16 04:50:31